LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹5.29 Cr | ₹1.95 Cr | ₹-22 Cr | ₹-63 Cr | ₹-12 Cr |
What is the latest Cash Flow from Financing Activities ratio of LYKA LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹5.29 Cr |
| Mar2024 | ₹1.95 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹-63 Cr |
| Mar2021 | ₹-12 Cr |
How is Cash Flow from Financing Activities of LYKA LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.29 Cr | 170.97 | |
| Mar2024 | ₹1.95 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹-63 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹218.7 Cr | -4.9% | -14% | -44.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -4.9% |
-14% |
-44.8% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses